Familial Longevity is Associated with an Attenuated Thyroidal Response to Recombinant Human Thyroid Stimulating Hormone

J Clin Endocrinol Metab. 2020 Jul 1;105(7):e2572-e2580. doi: 10.1210/clinem/dgaa195.

Abstract

Context: Longevity is associated with higher circulating levels of TSH in the absence of differences in circulating thyroid hormones (TH), as previously observed in F2 members of long-lived families (F2-LLS) and their partners (F2-Con). The mechanism underlying this observed difference remains unknown.

Objective: We hypothesized that the thyroid gland of members from long-lived families are less responsive to TSH stimulation, thereby requiring higher circulating TSH levels to maintain adequate TH levels.

Methods: We performed a case-control intervention study with a single intramuscular (gluteal) injection with 0.1 mg recombinant human TSH in a subgroup of 14 F2-LLS and 15 similarly aged F2-Con. They were followed for 4 days. No serious adverse events were reported. For analyses, we compared time trajectories of TSH and TH, and the ratio of TH to TSH using area under the curve (AUC) calculations.

Results: The AUC free T4/AUC TSH ratio was significantly lower in F2-LLS than in F2-Con (estimated mean [95% confidence interval] 1.6 [1.2-1.9] and 2.2 [1.9-2.6], respectively, P = 0.01). The AUC thyroglobulin/AUC TSH ratio was also lower in F2-LLS than in F2-Con (median [interquartile range] 2.1 [1.4-3.6] and 3.2 [2.7-7.4], respectively, P = 0.04). We observed the same trend with the AUC free T3/AUC TSH ratio, although the difference was not statistically significant (estimated mean [95% confidence interval] 0.6 [0.4-0.7] and 0.7 [0.6-0.8], respectively, P = 0.07).

Conclusions: The present findings show that members of long-living families have a lower thyroid responsivity to TSH compared with their partners.

Keywords: Thyroid; longevity; recombinant human TSH; responsivity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Case-Control Studies
  • Female
  • Humans
  • Longevity / genetics*
  • Male
  • Middle Aged
  • Recombinant Proteins / pharmacology*
  • Thyroid Gland / drug effects*
  • Thyrotropin / blood
  • Thyrotropin / pharmacology*
  • Thyroxine / blood
  • Triiodothyronine / blood

Substances

  • Recombinant Proteins
  • Triiodothyronine
  • Thyrotropin
  • Thyroxine

Associated data

  • EudraCT/2016-001497-15